- Home
- SGC vs NKTR Comparison
SGC vs NKTR Comparison
Compare SGC & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGC | NKTR |
|---|---|---|
| Founded | 1920 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 156.7M | 1.1B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | SGC | NKTR |
|---|---|---|
| Price | $10.05 | $43.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $17.33 | ★ $111.83 |
| AVG Volume (30 Days) | 60.1K | ★ 962.0K |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | ★ 5.55% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $565,017,000.00 | $62,600,000.00 |
| Revenue This Year | $0.73 | N/A |
| Revenue Next Year | $3.38 | N/A |
| P/E Ratio | $27.95 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.30 | $6.48 |
| 52 Week High | $16.91 | $66.92 |
Technical Indicators
Market Signals| Indicator | SGC | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 56.38 | 36.83 |
| Support Level | $9.63 | $42.95 |
| Resistance Level | $10.28 | $47.12 |
| Average True Range (ATR) | 0.31 | 3.88 |
| MACD | -0.01 | -1.19 |
| Stochastic Oscillator | 57.14 | 7.95 |
Price Performance
Historical ComparisonAbout SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.